Drug
burosumab
Marketed as CRYSVITA.
Generic name
burosumab
Brand names
CRYSVITA
First FDA approval
2018-04-17
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761068 | CRYSVITA | 2018-04-17 | KYOWA KIRIN |
Manufacturers
KYOWA KIRIN
Frequently asked questions
When was burosumab FDA approved?
Earliest FDA approval on record: 2018-04-17.
What brand names are sold as burosumab?
CRYSVITA.
Sources
Appeal a burosumab denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com